Results 21 to 30 of about 4,204,651 (354)

Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor. [PDF]

open access: yes, 2012
Pancreatic neuroendocrine tumors (PNETs) are relatively rare tumors that arise in the endocrine cells of the pancreas. Historically, somatostatin analogues have been used in this disease primarily for symptom control and, to a limited extent, disease ...
Devata, Sumana, Kim, Edward J
core   +5 more sources

En bloc Pancreaticodudenectomy with Colectomy for Locally Advanced Right Sided Colon Cancer

open access: yesJournal of Nepal Medical Association, 2015
A 57 year old male presented to our outpatient clinic with history of on and off melena, weight loss and decreasing appetite for 10 months duration and a noticeable mass on the right upper quadrant.
Ramesh Singh Bhandari   +2 more
doaj   +1 more source

Laryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers. [PDF]

open access: yes, 2019
For long, the treatment of locoregionally advanced laryngeal and hypopharyngeal squamous cell cancers (SCC) consisted of either total laryngectomy (TL) or definitive radiotherapy (RT).
Argiris, Athanassios   +1 more
core   +2 more sources

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

open access: yesThe Lancet Oncology, 2020
BACKGROUND Systemic relapses remain a major problem in locally advanced rectal cancer. Using short-course radiotherapy followed by chemotherapy and delayed surgery, the Rectal cancer And Preoperative Induction therapy followed by Dedicated Operation ...
R. Bahadoer   +19 more
semanticscholar   +1 more source

Locally Advanced Pancreatic Cancer

open access: yesJOP : Journal of the pancreas, 2013
Treatment of locally advanced pancreatic cancer is palliative, based on chemotherapy and according to response, chemoradiotherapy can be applied. The authors summarize three abstracts (#LBA146, #256 and #303) presented on the 2013 ASCO Gastrointestinal Cancers Symposium, which were focused on treatment of locally advanced pancreatic cancer.
Georgios M, Oikonomopoulos   +3 more
openaire   +2 more sources

Clinical predictive factors of pathologic complete response in locally advanced rectal cancer [PDF]

open access: yes, 2016
Background: Predictive factors of pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) are still not identified. The purpose of this study was to define them. Materials and Methods: Data
Bulzonetti, Nadia   +10 more
core   +1 more source

Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.

open access: yesThe Lancet Digital Health, 2022
BACKGROUND Accurate prediction of tumour response to neoadjuvant chemoradiotherapy enables personalised perioperative therapy for locally advanced rectal cancer.
Li-Li Feng   +24 more
semanticscholar   +1 more source

Monitoring Breast Cancer Response to Neoadjuvant Chemotherapy Using Ultrasound Strain Elastography [PDF]

open access: yes, 2019
© 2019 The Authors Strain elastography was used to monitor response to neoadjuvant chemotherapy (NAC) in 92 patients with biopsy-proven, locally advanced breast cancer. Strain elastography data were collected before, during, and after NAC.
Curpen, B.   +12 more
core   +1 more source

6.3 MeV fast neutrons in the treatment of patients with locally advanced and locally recurrent breast cancer [PDF]

open access: yes, 2016
The study included 135 breast cancer patients (70 patients with locally recurrent breast cancer and 65 patients with locally advanced breast cancer with unfavorable prognostic factors) who received the neutron therapy alone or in combination with the ...
Lisin, V. A.   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy